Marc Kung

Fribourg, FR, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

A retrospective cross-sectional survey of symptoms, comorbidities, return to work, and financial problems experienced by cancer survivors up to 10 years post-diagnosis.

A retrospective cross-sectional survey of symptoms, comorbidities, return to work, and financial problems experienced by cancer survivors up to 10 years post-diagnosis.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: May 20, 2026

Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.

Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment.

Journal: European urology open science
Published: March 03, 2023

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08.

Journal: BMC cancer
Published: October 13, 2019

Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation

Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation

Journal: Praxis
Published: September 20, 2018

Correction: Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients.

Correction: Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients.

Journal: Cureus
Published: August 15, 2018

Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients.

Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients.

Journal: Cureus
Published: August 07, 2018

Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10.

Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10.

Journal: Journal of geriatric oncology
Published: June 27, 2018

Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.

Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: June 03, 2018

Unusual Case of Laryngeal Squamous Cell Carcinoma with Cervical Metastasis of a Prostatic Adenocarcinoma: A Case Report.

Unusual Case of Laryngeal Squamous Cell Carcinoma with Cervical Metastasis of a Prostatic Adenocarcinoma: A Case Report.

Journal: Case reports in oncology
Published: March 08, 2017

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.

Journal: BMC cancer
Published: January 12, 2016

Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study.

Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study.

Journal: Oncology research and treatment
Published: December 16, 2013

Predictors of venous thromboembolic events associated with central venous port insertion in cancer patients.

Predictors of venous thromboembolic events associated with central venous port insertion in cancer patients.

Journal: Journal of oncology
Published: August 29, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026